Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122


A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors.

Grant IA, Rodriguez CO, Kent MS, Sfilgoi G, Gordon I, Davis G, Lord L, London CA.

J Vet Intern Med. 2008 Mar-Apr;22(2):388-93. doi: 10.1111/j.1939-1676.2008.0051.x.


Treatment of canine mast cell tumors with CCNU (lomustine).

Rassnick KM, Moore AS, Williams LE, London CA, Kintzer PP, Engler SJ, Cotter SM.

J Vet Intern Med. 1999 Nov-Dec;13(6):601-5.


Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997).

Thamm DH, Mauldin EA, Vail DM.

J Vet Intern Med. 1999 Sep-Oct;13(5):491-7.


Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.

Taylor F, Gear R, Hoather T, Dobson J.

J Small Anim Pract. 2009 Jun;50(6):284-9. doi: 10.1111/j.1748-5827.2009.00732.x.


Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.

Carlsten KS, London CA, Haney S, Burnett R, Avery AC, Thamm DH.

J Vet Intern Med. 2012 Jan-Feb;26(1):135-41. doi: 10.1111/j.1939-1676.2011.00851.x.


Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors.

Davies DR, Wyatt KM, Jardine JE, Robertson ID, Irwin PJ.

J Am Anim Hosp Assoc. 2004 Mar-Apr;40(2):124-30.


Adverse haematological effects of vinblastine, prednisolone and cimetidine treatment: a retrospective study in fourteen dogs with mast cell tumours.

Trumel C, Bourgès-Abella N, Touron C, Lanore D, Geffré A, Diquelou A, Guelfi JF, Braun JP.

J Vet Med A Physiol Pathol Clin Med. 2005 Aug;52(6):275-9.


A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs.

Vail DM, von Euler H, Rusk AW, Barber L, Clifford C, Elmslie R, Fulton L, Hirschberger J, Klein M, London C, Martano M, McNiel EA, Morris JS, Northrup N, Phillips B, Polton G, Post G, Rosenberg M, Ruslander D, Sahora A, Siegel S, Thamm D, Westberg S, Winter J, Khanna C.

J Vet Intern Med. 2012 May-Jun;26(3):598-607. doi: 10.1111/j.1939-1676.2012.00897.x.


Toxicity, dosage, and efficacy of vinorelbine (Navelbine) in dogs with spontaneous neoplasia.

Poirier VJ, Burgess KE, Adams WM, Vail DM.

J Vet Intern Med. 2004 Jul-Aug;18(4):536-9.


Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Lejeune A, Skorupski K, Frazier S, Vanhaezebrouck I, Rebhun RB, Reilly CM, Rodriguez CO Jr.

Vet Comp Oncol. 2015 Sep;13(3):267-80. doi: 10.1111/vco.12042. Epub 2013 May 31.


Dose-escalating vinblastine for the treatment of canine mast cell tumour.

Vickery KR, Wilson H, Vail DM, Thamm DH.

Vet Comp Oncol. 2008 Jun;6(2):111-9. doi: 10.1111/j.1476-5829.2007.00147.x.


A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.

Rassnick KM, Bailey DB, Russell DS, Flory AB, Kiselow MA, Intile JL, Malone EK, Balkman CE, Barnard SM.

Vet Comp Oncol. 2010 Jun;8(2):138-52. doi: 10.1111/j.1476-5829.2010.00217.x.


A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs.

al-Sarraf R, Mauldin GN, Patnaik AK, Meleo KA.

J Vet Intern Med. 1996 Nov-Dec;10(6):376-8.


Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001).

Gieger TL, Théon AP, Werner JA, McEntee MC, Rassnick KM, DeCock HE.

J Vet Intern Med. 2003 Sep-Oct;17(5):687-92.


Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.

Stanclift RM, Gilson SD.

J Am Vet Med Assoc. 2008 Jan 1;232(1):53-62. doi: 10.2460/javma.232.1.53.


Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.

Arnold EJ, Childress MO, Fourez LM, Tan KM, Stewart JC, Bonney PL, Knapp DW.

J Vet Intern Med. 2011 Nov-Dec;25(6):1385-90. doi: 10.1111/j.1939-1676.2011.00796.x.


Clinical effects of vinorelbine administration in the management of various malignant tumor types in dogs: 58 cases (1997-2012).

Wouda RM, Miller ME, Chon E, Stein TJ.

J Am Vet Med Assoc. 2015 Jun 1;246(11):1230-7. doi: 10.2460/javma.246.11.1230.


A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.

Whitehead RP, Moon J, McCachren SS, Hersh EM, Samlowski WE, Beck JT, Tchekmedyian NS, Sondak VK; Southwest Oncology Group.

Cancer. 2004 Apr 15;100(8):1699-704.


Vinorelbine rescue therapy for dogs with primary urinary bladder carcinoma.

Kaye ME, Thamm DH, Weishaar K, Lawrence JA.

Vet Comp Oncol. 2015 Dec;13(4):443-51. doi: 10.1111/vco.12065. Epub 2013 Aug 25.

Items per page

Supplemental Content

Support Center